BMX-001 as a Radio-Protector in Head and Neck Cancer Therapy Phase I and Phase II
Research Grant
Administered By
Radiation Oncology
Awarded By
BioMimetix Pharmaceutical, Inc.
Start Date
March 1, 2017
End Date
May 8, 2022
Administered By
Radiation Oncology
Awarded By
BioMimetix Pharmaceutical, Inc.
Start Date
March 1, 2017
End Date
May 8, 2022